Archive for October 23rd, 2009
Friday, October 23rd, 2009
Catalent Develops New Decorin Molecule Form, Strikes Deal With Euclid
Released on: October 23, 2009, 7:46 am
Author: Jennings and Co.
Industry: Pharmaceuticals
SOMERSET, NJ -Catalent Pharma Solutions, a leading provider of advanced technologies and outsourced development and clinical services to the global pharmaceutical andbiotechnology industry, has announced the development of the Galacorin™ molecule, a proprietary form of the decorin molecule.
Catalent combined its proprietary GPEx® gene expression technology, Triplet-FixTM [...]